ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

75.76

-2.49 (-3.18%)

At close: Aug 10, 2026, 4:00 PM EDT

76.76

+1.00 (1.32%)

After-hours: Aug 10, 2026, 7:46 PM EDT

ANI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	360.21	285.59	144.86	221.12	48.23	100.3
Short-Term Investments	15.63	9.13	6.31	-	-	-
Cash & Short-Term Investments	375.84	294.72	151.17	221.12	48.23	100.3
Cash Growth	68.15%	94.96%	-31.64%	358.49%	-51.92%	1175.43%
Accounts Receivable	274.47	281.08	221.73	162.08	165.44	128.53
Inventory	143.15	143.07	136.78	111.2	105.36	81.69
Other Current Assets	31.98	34.25	18.01	25.42	25.24	11.26
Total Current Assets	825.43	753.12	527.68	519.82	344.26	321.78
Net Property, Plant & Equipment	73.22	62.48	56.86	44.59	43.25	52.67
Other Intangible Assets	449.86	479.53	541.83	209.01	251.64	294.12
Goodwill	62.48	62.48	59.99	28.22	28.22	27.89
Other Long-Term Assets	83.12	82.78	97.33	102.78	92.72	75.14
Total Assets	1,494	1,440	1,284	904.42	760.09	771.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	73.83	62.58	45.66	36.68	29.31	22.97
Accrued Expenses	140.95	146.52	92.8	57.84	35.89	27.89
Short-Term Debt	21.33	17.27	9.17	0.85	0.85	0.83
Other Current Liabilities	47.55	51.74	46.05	50.11	33.4	35.83
Total Current Liabilities	283.66	278.11	193.68	145.48	99.44	87.54
Long-Term Debt	589.16	599.77	614.92	284.82	285.67	286.52
Other Long-Term Liabilities	24.08	21.77	46.57	16.53	36.44	38.8
Total Long-Term Liabilities	613.25	621.54	661.49	301.35	322.11	325.32
Total Liabilities	896.9	899.65	855.17	446.82	421.55	412.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Treasury Stock	-53.82	-33.25	-21.04	-10.08	-5.09	-3.14
Additional Paid-in Capital	620.25	596.04	519.65	514.1	403.9	387.84
Accumulated Other Comprehensive Income	-0.33	1.03	5.34	8.86	12.17	-3.06
Retained Earnings	31.1	-23.1	-100.28	-80.13	-97.29	-47.77
Total Common Shareholders' Equity	597.21	540.72	403.68	432.75	313.69	333.89
Minority Interest	-	-	24.85	24.85	24.85	24.85
Shareholders' Equity	597.21	540.72	428.53	457.6	338.54	358.74
Total Liabilities & Equity	1,494	1,440	1,284	904.42	760.09	771.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	610.49	617.04	624.09	285.67	286.52	287.35
Net Cash (Debt)	-234.66	-322.32	-472.92	-64.55	-238.29	-187.05
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.00	-15.18	-24.48	-3.55	-14.65	-14.93
Book Value	597.21	540.72	403.68	432.75	313.69	333.89
Book Value Per Share	28.00	25.47	20.90	23.79	19.29	26.65
Tangible Book Value	84.88	-1.28	-198.14	195.52	33.83	11.88
Tangible Book Value Per Share	3.98	-0.06	-10.26	10.75	2.08	0.95

SEC Filings: 10-K · 10-Q